EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudie

Lipid-based amphotericin B formulations (ABCD/L-AmB) were associated with better outcomes than deoxycholate (AmB-d) in non-HIV-associated cryptococcal meningitis: A retrospective cohort study

Junyu Liu iD, Jia Liu, Min Li, Ruiqi Dong, Dongcheng Li, Jiajie Chen, Wenhai Zeng, Zheqi Li, Xiaofeng Xu, Ying Jiang, Fuhua Peng

Medical Mycology · 01.05.2026 · 64 (5)

DOI: 10.1093/mmy/myag033 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Medical Mycology, online erschienen am 16.04.2026. Verfasst von Junyu Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, PR China. Hauptthemen laut MEDLINE: Amphotericin B, Meningitis, Cryptococcal, Antifungal Agents, Deoxycholic Acid. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Clinical High-tech, Characteristic Technology Projects in Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This retrospective cohort study compared the efficacy and safety of lipid-based amphotericin B formulations (amphotericin B colloidal dispersion [ABCD] and liposomal amphotericin B [L-AmB]) versus conventional amphotericin B deoxycholate (AmB-d) for the treatment of non-human immunodeficiency virus (HIV)-associated cryptococcal meningitis (CM). Data from 199 patients were analyzed, divided into three groups based on induction therapy: AmB-d (n = 110), ABCD (n = 44), and L-AmB (n = 45). At baseline, a higher proportion of patients in the lipid-based groups presented with altered mental status. After 2 weeks, the ABCD and L-AmB groups showed significantly better clinical improvement (as measured by British Medical Research Council Stage 1) compared to the AmB-d group (63.6% and 77.8% vs. 35.5%; P < .001), and experienced substantially lower rates of renal impairment (54.5% and 53.3% vs. 79.1%; P = .001). Early fungicidal activity was similar across all groups. Multivariate analysis at 10 weeks indicated that both lipid-based formulations were associated with a lower risk of unsuccessful outcomes compared to AmB-d. Furthermore, 1-year survival analysis for clinical cure demonstrated a significantly higher cumulative incidence in the lipid-based AmB groups (Log-rank test, P = .016). In conclusion, induction regimens based on ABCD or L-AmB were associated with better outcomes than AmB-d for non-HIV-associated CM, offering better long-term outcomes and a more favorable safety profile, particularly regarding kidney toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amphotericin BMeningitis, CryptococcalAntifungal AgentsDeoxycholic AcidHumansRetrospective StudiesTreatment OutcomeFemaleMaleAdultMiddle AgedDrug Combinations

Stichwörter der Autor:innen

amphotericin Bcryptococcal meningitisefficacynon-human immunodeficiency virussafety

Substanzen

Amphotericin BAntifungal AgentsDeoxycholic Acidliposomal amphotericin Bamphotericin B, deoxycholate drug combinationDrug Combinations

Autor:innen und Institutionen

  • Department of Neurology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, PR China.

ORCID-Profile: Junyu Liu

Förderung

  • Clinical High-tech
  • Characteristic Technology Projects in Guangzhou

Zitieren

APA

Liu, J., Liu, J., Li, M., Dong, R., Li, D., Chen, J., Zeng, W., Li, Z., Xu, X., Jiang, Y., & Peng, F. (2026). Lipid-based amphotericin B formulations (ABCD/L-AmB) were associated with better outcomes than deoxycholate (AmB-d) in non-HIV-associated cryptococcal meningitis: A retrospective cohort study. Medical Mycology, 64(5). https://doi.org/10.1093/mmy/myag033

Vancouver

Liu J, Liu J, Li M, Dong R, Li D, Chen J, et al. Lipid-based amphotericin B formulations (ABCD/L-AmB) were associated with better outcomes than deoxycholate (AmB-d) in non-HIV-associated cryptococcal meningitis: A retrospective cohort study. Medical Mycology. 2026;64(5). doi:10.1093/mmy/myag033

BibTeX
@article{Liu2026,
  author = {Liu, Junyu and Liu, Jia and Li, Min and Dong, Ruiqi and Li, Dongcheng and Chen, Jiajie and Zeng, Wenhai and Li, Zheqi and Xu, Xiaofeng and Jiang, Ying and Peng, Fuhua},
  title = {Lipid-based amphotericin B formulations (ABCD/L-AmB) were associated with better outcomes than deoxycholate (AmB-d) in non-HIV-associated cryptococcal meningitis: A retrospective cohort study},
  journal = {Medical Mycology},
  year = {2026},
  volume = {64},
  number = {5},
  doi = {10.1093/mmy/myag033}
}
Kostenlos starten →